← Leaderboards
Jorge A Ghiso
Nathan S. Kline Institute For Psych Res
$12,759,277
Attributed
$12,990,699
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.7M · FY2005–20$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$12,990,699 · 9
By mechanism
RF1$6,824,854 · 2
R01$3,529,751 · 2
R21$1,392,553 · 3
P01$1,243,541 · 2
Top collaborators
- Jorge A Busciglio2 shared
Most similar at Nathan S. Kline Institute For Psych Res
Same institution · by research overlap
- Thomas M Wisniewski$40,874,523
Others in their field
Top investigators on “Lesion”
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$112,011,044
- Ronald T Mitsuyasu · University Of California Los Angeles$100,903,367
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,218,842
- John Anthony Baron · Dartmouth College$46,892,408
- C Kent Osborne · Baylor College Of Medicine$45,919,490
Research focus
LesionDepositionAlzheimer&AposProductionCellsIn VitroS DiseaseBrainIn VivoAffectAnimal ModelAmyloidCerebrumHomeostasisAmyloid Beta-ProteinPathway InteractionsComplexNeurotoxicPlayAmyloid FormationImpaired CognitionPathogenesisBiologicalBiochemical
Grant awards (29)
Cerebral amyloid angiopathy, metabolic dysregulation, and the neurovascular unit - Resubmission - 1$3,164,945
RF1 · FY2020 · AG · contact PI
Relevance of Abeta N-terminal Truncations for Alzheimer Pathogenesis and Therapy - Resubmission - 1$3,659,909
RF1 · FY2019 · AG · contact PI
Insights into the Brain Clearance Mechanisms of Oligomeric Beta-Amyloid Species$211,875
R21 · FY2016 · AG · contact PI
Insights into the Brain Clearance Mechanisms of Oligomeric Beta-Amyloid Species$254,250
R21 · FY2015 · AG · contact PI
iPSC from British and Danish dementias: new discovery tools for brain amyloidoses$202,501
R21 · FY2014 · AG · contact PI
Cerebral Amyloidosis and Dementia$347,985
R01 · FY2013 · AG · contact PI
Cerebral Amyloidosis and Dementia$312,468
R01 · FY2013 · AG · contact PI
iPSC from British and Danish dementias: new discovery tools for brain amyloidoses$260,344
R21 · FY2013 · AG · contact PI
Cerebral Amyloidosis and Dementia$399,092
R01 · FY2012 · AG · contact PI
Cerebral Amyloidosis and Dementia$68,438
R01 · FY2012 · AG · contact PI
Cerebral Amyloidosis and Dementia$330,654
R01 · FY2011 · AG · contact PI
Cerebral Amyloidosis and Dementia$344,000
R01 · FY2010 · AG · contact PI
Exfoliation Syndrome: Development of a cell culture model of fibril formation$251,708
R21 · FY2010 · EY · contact PI
Cerebral Amyloidosis and Dementia$347,475
R01 · FY2009 · AG · contact PI
APOLIPOPROTEINS AND A-BETA CATABOLISM$279,283
P01 · FY2009 · AG · contact PI
Exfoliation Syndrome: Development of a cell culture model of fibril formation$211,875
R21 · FY2009 · EY · contact PI
Cerebral Amyloidosis and Dementia$60,782
R01 · FY2009 · AG · contact PI
APOLIPOPROTEINS AND A-BETA CATABOLISM$307,003
P01 · FY2008 · AG · contact PI
APOLIPOPROTEINS AND A-BETA CATABOLISM$310,904
P01 · FY2007 · AG · contact PI
APOLIPOPROTEINS AND A-BETA CATABOLISM$222,223
P01 · FY2006 · AG · contact PI
APOLIPOPROTEINS AND A-BETA CATABOLISM$124,128
P01 · FY2005 · AG
ALZHEIMER AMYLOID B AND THE AGED CEREBRAL VESSEL WALL$282,313
R01 · FY2004 · NS
ALZHEIMER AMYLOID B AND THE AGED CEREBRAL VESSEL WALL$273,699
R01 · FY2003 · NS
ALZHEIMER AMYLOID B AND THE AGED CEREBRAL VESSEL WALL$265,350
R01 · FY2002 · NS
Soluble Amyloid Beta, apolipoproteins, and Alzheimer's Disease$0
P01 · FY2002 · AG
ALZHEIMER AMYLOID B AND THE AGED CEREBRAL VESSEL WALL$257,253
R01 · FY2001 · NS
Soluble Amyloid Beta, apolipoproteins, and Alzheimer's Disease$0
P01 · FY2001 · AG
ALZHEIMER AMYLOID B AND THE AGED CEREBRAL VESSEL WALL$240,242
R01 · FY2000 · NS
Soluble Amyloid Beta, apolipoproteins, and Alzheimer's Disease$0
P01 · FY2000 · AG